R&D Systems, Inc.

11 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Aug 2036

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Mar 19, 2027
The maintenance fee for Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (US 11,760,983) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,790,467	Methods and compositions for activation or expansion of T lymphocytes In force Term ends Aug 4, 2036 · From the USPTO record	In force	Term ends Aug 4, 2036	From the USPTO record
US 10,739,338	Shaped articles including hydrogels and methods of manufacture and use thereof In force Term ends Aug 10, 2036 · From the USPTO record	In force	Term ends Aug 10, 2036	From the USPTO record
US 10,227,574	ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS In force Ends no later than Dec 15, 2037 · Medium confidence	In force	Ends no later than Dec 15, 2037	Medium confidence
US 11,111,483	Enhanced Hat Family Transposon-Mediated Gene Transfer and Associated Compositions, Systems and Methods In force Term ends Dec 15, 2037 · Medium confidence	In force	Term ends Dec 15, 2037	Medium confidence
US 11,162,084	Enhanced hAT Family Transposon-Mediated Gene Transfer and Associated Compositions, Systems, and Methods In force Term ends Dec 15, 2037 · Medium confidence	In force	Term ends Dec 15, 2037	Medium confidence
US 11,278,570	ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS In force Term ends Dec 15, 2037 · Medium confidence	In force	Term ends Dec 15, 2037	Medium confidence
US 12,037,611	Enhanced hAT Family Transposon-Mediated Gene Transfer and Associated Compositions, Systems, and Methods In force Term ends Dec 15, 2037 · Medium confidence	In force	Term ends Dec 15, 2037	Medium confidence
US 12,097,220	ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS In force Term ends Dec 15, 2037 · High confidence	In force	Term ends Dec 15, 2037	High confidence
US 11,760,983	Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods In force Term ends Sep 28, 2039 · From the USPTO record	In force	Term ends Sep 28, 2039	From the USPTO record
US 11,565,237	Compositions, Devices, and Methods for Cell Separation In force Ends no later than Jun 3, 2040 · Medium confidence	In force	Ends no later than Jun 3, 2040	Medium confidence

10 of 11 patents shown.

Pro members see all 11.

Pro members: see all 11 patents

Also on record, not counted in the 11: 1 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro